Scherbel, Schuchter, and Weyman (1957) reported that the local injection of nitrogen mustard directly into rheumatoid joints was safe, and that the injected joints appeared to improve. More recently, Wenley and Glick (1964) at the London Hospital, and Flatt (1962) in the United States have been using triethylene thiophosphamide (Thiotepa, Lederle. Flatt's preliminary report was encouraging, and Wenley and Glick also noted slight improvement after Thiotepa injections into knee joints. However, the dose used in knee joints was limited because of possible systemic toxic effects-the drug is a bone marrow depressant and presumably has mutagenic effects-with the result that a limited dose was acting in a joint with a large synovial surface. It was felt that a more clear-cut result would be obtained using finger joints, allowing a relatively larger dose of the drug to act on the smaller area of synovium. The trial here reported, a continuation of the work begun by Wenley, was designed to assess the effect of single injections of Thiotepa into finger joints and, in a few cases, to follow the changes in synovial histology and fluid following the injections.
Clinical Trial Material
Patients were selected with a comparable pair of proximal interphalangeal (PIP) or metacarpo-phalangeal (MCP) joints showing both soft tissue swelling and tenderness. The stage of involvement varied from joints not yet showing erosions to those with extensive changes. Fifty patients completed the trial (with one defaulter). Of these, two were classified as having psoriatic arthropathy, and the remainder "definite rheumatoid arthritis".
Method
One of each pair ofjoints was selected at random to be injected with a Thiotepa solution prepared by dissolving 15 mg. of the powder in 3 ml. of 1 per cent. procaine solution. Injections were made through the middle of the extensor expansion using a No. 18 needle. The position of the needle within the joint was confirmed by flushing out with procaine, before injecting as much of the Thiotepa solution as the joint would accommodate without undue tension, to a maximum of 1 ml. Doses varied from 0 * 4 to 1 -0 ml. (2 to 5 mg.), average 3 * 5 mg. The control joint was injected with a similar volume of I per cent. procaine solution.
The joints were examined before injection and at 2, 6, 10, 16, and 26 
Conclusions
The improvement seen in treated and control joints, by all criteria both subjective and objective, suggests that the joints did in fact improve during the period of observation. The possible causes for this improvement all appear rather unlikelyneither the mechanical trauma of the procedure, nor the chemical effect of the procaine would be expected to have any long-term effect, although it would be of interest to test this. Alternatively, some of these patients did become rather introspective about the injected joints and carried out repeated measurements themselves; it is possible that awareness of the trial and curiosity of this sort may have provoked sufficient exercise of these joints to modify their clinical state. Whatever the explanation it is clear that Thiotepa, as used in this trial, had no advantage over procaine.
Pathological Studies
While the clinical trial was in progress, some pathological studies were undertaken in an attempt to throw light on the mode of action of Thiotepa in rheumatoid joints. These were discontinued when it became apparent that the drug was ineffective clinically, and the study is therefore incomplete. Some of the results are, however, thought to be of sufficient interest to merit reporting briefly.
Histology
Seven rheumatoid patients who were about to undergo surgical synovectomy of finger joints were given a single injection of Thiotepa into one or more of the joints selected for operation. Ten injections were carried out at intervals varying from 3 days to 22 weeks before operation, the non-injected joints acting as controls. At operation two small sections of the synovium were rapidly frozen for immunofluorescent studies, the remainder of the specimen was examined by standard histological methods.
The problem of sampling and the fact that the material was not obtained from the same joints before and after injections make interpretation of the findings difficult, and it is not possible from such a limited number of specimens to form a clear picture of the histological sequence of events following the injections. Immunofluorescent studies were carried out on most of these specimens in an attempt to find out whether Thiotepa modified the numbers of rheumatoid factor containing cells present-for it has been suggested by Flatt (1962) Fig. 6 shows the titre of rheumatoid factor (latexfixation test) in these specimens. An interesting result to emerge was a consistent fall in the titre of rheumatoid factor not only in the synovial fluid but in the serum. A similar result has been reported by Gross (1963) , although Zuckner, Uddin, Ramsey, Gantner, Ahern, and Dorner (1964) found no such changes. The limited number of tubes used in these tests was insufficient to record some of the higher titres-nevertheless the trend seems definite, with a fall in titre of approximately three tubes in both fluids. Protein determinations carried out on the same specimens suggested that overall protein changes were not responsible for this fall in titre ( In an effort to document these changes more precisely immuno-electrophoresis was carried out on all specimens. The findings in all the fluids were very similar and two examples are shown in Fig. 7 (opposite); in contrast with normal synovial fluids these specimens showed a marked increase in all three immunoglobulins, which is essentially unchanged by Thiotepa treatment.
Summary and Conclusions
Intra-articular injections of Thiotepa into rheumatoid finger-joints produced some clinical improvement which was still apparent after 6 months. Control joints injected with procaine showed a similar improvement.
Histologically, Thiotepa reduced the numbers of inflammatory cells in the treated synovia, while intra-articular injections of larger doses into knee joints produced a fall in rheumatoid factor titre both in the synovial fluid and in the blood. Despite the theoretical attractions of administering cytotoxic drugs directly into rheumatoid joints, and the marked histological changes which this has been shown to produce, it is concluded that injecting Thiotepa into rheumatoid finger joints, as carried out in this trial, is not a worth-while procedure. 
